388 filings
Page 7 of 20
6-K
GMAB
Genmab
27 Sep 22
Capital Increase in Genmab as a Result of Employee Warrant Exercise
12:51pm
6-K
GMAB
Genmab
26 Sep 22
Current report (foreign)
9:30am
6-K
GMAB
Genmab
20 Sep 22
Current report (foreign)
3:31pm
6-K
GMAB
Genmab
1 Sep 22
Completion of share buy-back program
12:41pm
6-K
GMAB
Genmab
29 Aug 22
Current report (foreign)
9:38am
6-K
GMAB
Genmab
24 Aug 22
Current report (foreign)
3:04pm
6-K
GMAB
Genmab
22 Aug 22
Current report (foreign)
9:05am
6-K
GMAB
Genmab
17 Aug 22
Current report (foreign)
1:33pm
6-K
GMAB
Genmab
17 Aug 22
Current report (foreign)
10:48am
6-K
GMAB
Genmab
16 Aug 22
Capital Increase in Genmab as a Result of Employee Warrant Exercise
2:40pm
6-K
GMAB
Genmab
15 Aug 22
Current report (foreign)
9:14am
6-K
GMAB
Genmab
10 Aug 22
Genmab Announces Financial Results for the First Half of 2022
11:25am
6-K
GMAB
Genmab
8 Aug 22
Genmab Improves Its 2022 Financial Guidance
12:49pm
6-K
GMAB
Genmab
8 Aug 22
Current report (foreign)
8:29am
6-K
GMAB
Genmab
2 Aug 22
Major Shareholder Announcement
3:08pm
6-K
GMAB
Genmab
1 Aug 22
Current report (foreign)
10:42am
6-K
GMAB
Genmab
25 Jul 22
Current report (foreign)
8:40am
6-K
GMAB
Genmab
20 Jul 22
Major Shareholder Announcement
2:02pm
6-K
GMAB
Genmab
19 Jul 22
Genmab Announces Net Sales of DARZALEX® (daratumumab) for the Second Quarter of 2022
8:14am
6-K
GMAB
Genmab
18 Jul 22
Current report (foreign)
11:08am